查詢結果分析
相關文獻
- Measurement of the Quality of Life during Different Clinical Phases of Breast Cancer
- 運用國際健康功能與身心障礙分類模式於乳癌個案之復健治療
- 以病人為中心的護理--帕西護理實務法
- 護理一位乳癌病人之護病關係進展過程--Peplau理論之臨床應用
- 放射治療後長期存活之鼻咽癌病人的生活品質調查
- Factors Related to Quality of Life in Breast Cancer Patients Receiving Chemotherapy
- 探討乳癌病人的症狀困擾、自我效能、社會支持與生活品質之關係
- Immunohistochemical Analyses of p53 Protein Expression in Breast Cancers in Taiwan: A Clinicopathologic Study
- Expression of P53 Protein and It's Prognostic Significance in Breast Cancer Patients
- 臺灣地區乳癌病友團體成員參與和滿意度研究
頁籤選單縮合
題 名 | Measurement of the Quality of Life during Different Clinical Phases of Breast Cancer=乳癌不同臨床階段病人生活品質之測量 |
---|---|
作 者 | 季瑋珠; 黃俊升; 陳人豪; 張金堅; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 98:4 1999.04[民88.04] |
頁 次 | 頁254-260 |
分類號 | 419.77 |
關鍵詞 | 乳癌; 臨床階段; 病人; 生活品質; Quality of life; Breast cancer; Chemotherapy; |
語 文 | 英文(English) |
英文摘要 | This cross-sectional study was designed to evaluate the self-rated quality of life of Taiwanese breast cancer patients at the time of diagnosis and during various phases of treatment. A total of 115 patients at different clinical stages of breast cancer completed the study. The questionnaires consisted of the Medical Outcome Survey 36-ltem Short Form Health Surveys (SF-36), the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire—Cancer 30 (EORTC QLQ-C30), and questions measuring utility using visual analog scale (VAS), standard gamble (SG), and time trade-off (TTO) methods. The patients filled out the questionnaires, with interviewers' assistance as requested, Cronbach's alpha coefficients of internal consistency for the SF-36, based on the US factor structure, were 0.84 for raw scores and 0.87 and 0.88 for the physical and mental components, respectively. Cronbach's alpha for the EORTC QLQ-C30 was 0.86. The correlations between items in the SF-36 and the EORTC QLQ-C30 that examiner similar dimensions were high. Significant differences were found inmost dimensions of quality of life across different clinical stages. The three utility scores, however, showed no significant differences among patients in different clinical stages. Patients in the chemotherapy and recurrence phases usually had the lowest quality of life scores, while those in the follow-up phase had the highest. The results of this study demonstrate the applicability of quality of life measurements in helping health professionals identify the physical, mental, and social problems of breast cancer patients in different phases of the clinical process. |
本系統中英文摘要資訊取自各篇刊載內容。